Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial

Britt Kveiborg, Atheline Major-Petersen, Buris Christiansen, Christian Torp-PedersenDepartment of Cardiology, Bispebjerg University Hospital, Copenhagen, DenmarkAbstract: Beta-blockers have been shown to improve survival in patients with chronic heart failure. The effect of different generations of...

Full description

Bibliographic Details
Main Authors:	Britt Kveiborg, Atheline Major-Petersen, Buris Christiansen, Christian Torp-Pedersen
Format:	Article
Language:	English
Published:	Dove Medical Press 2007-03-01
Series:	Vascular Health and Risk Management
Online Access:	https://www.dovepress.com/carvedilol-in-the-treatment-of-chronic-heart-failure-lessons-from-the--peer-reviewed-article-VHRM

Similar Items

Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study
by: Køber Lars, et al.
Published: (2011-10-01)

Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study
by: Raunsø Jakob, et al.
Published: (2010-05-01)

Metoprolol vs carvedilol in heart failure
by: Norton Michael, et al.
Published: (2000-10-01)

Carvedilol versus Metoprolol in Patients with Ventricular Tachyarrhythmias
by: Tobias Schupp, et al.
Published: (2022-08-01)

Carvedilol in the treatment of elderly patients with chronic heart failure
by: Klaus KA Witte, et al.
Published: (2008-03-01)

Long‐Term Mortality Associated With Use of Carvedilol Versus Metoprolol in Heart Failure Patients With and Without Type 2 Diabetes: A Danish Nationwide Cohort Study
by: Brian Schwartz, et al.
Published: (2021-09-01)

ANTIHYPERTENSIVE AND ANTIOXIDATIVE EFFECTS OF CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT/OBESITY
by: V. A. Nevzorova, et al.
Published: (2016-01-01)

EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS
by: A. R. Kiselev, et al.
Published: (2016-01-01)

EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS
by: A. R. Kiselev, et al.
Published: (2016-01-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

Carvedilol and metoprolol are both able to preserve myocardial function in type 2 diabetes
by: Carol T. Bussey, et al.
Published: (2020-03-01)

Carvedilol therapy effects on structural and electric remodeling in chronic heart failure
by: E. V. Minakov, et al.
Published: (2008-02-01)

THE EFFECTIVENESS OF CARVEDILOL AND EPROSARTAN IN PATIENTS WITH METABOLIC SYNDROME AND CHRONIC HEART FAILURE
by: R. L. Dashnamirov
Published: (2014-04-01)

CAMELLIA TRIAL: COMPARISON IN THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10‐Year Cohort
by: Chao‐Hsiun Tang, et al.
Published: (2016-01-01)

Immunopharmacological Approach of Carvedilol in Chronic Chagas Heart Disease
by: Carla Paixão Miranda, et al.
Published: (2014-10-01)

Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure
by: A. I. Chesnikova, et al.
Published: (2008-06-01)

Is carvedilol better than other beta-blockers for heart failure?
by: Carmen Rain, et al.
Published: (2015-06-01)

COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures
by: Aaron I. Vinik, et al.
Published: (2014-08-01)

Carvedilol in hypertension treatment
by: Panagiotis C Stafylas, et al.
Published: (2008-02-01)

Carvedilol—NSBB of choice in all cirrhotics? Short title: Carvedilol for portal hypertension
by: Puneeta Tandon, et al.
Published: (2015-01-01)

Substituição do carvedilol pelo propranolol em pacientes com insuficiência cardíaca Sustitución del carvedilol por el propranolol en pacientes con insuficiencia cardíaca Replacement of carvedilol for propranolol in patients with heart failure
by: Fabiana Marques, et al.
Published: (2010-07-01)

Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of clinical results
by: Heather L. Bloom, et al.
Published: (2014-08-01)

Carvedilol and its combination with digoxin for heart rate control in patients with persistent atrial fibrillation and chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

Carvedilol in the treatment of portal hypertension
by: Hamdan Al-Ghamdi
Published: (2011-01-01)

COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY
by: I. V. Zhirov, et al.
Published: (2015-09-01)

COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY
by: I. V. Zhirov, et al.
Published: (2015-09-01)

A comparison between Captopril, Valsartan, Carvedilol and Conventional therapy in the treatment of heart failure
by: Al-Mousilly M. Maiada
Published: (2005-12-01)

The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction
by: Ki Hong Choi, et al.
Published: (2019-09-01)

Carvedilol Alters Circulating MiR-1 and MiR-214 in Heart Failure
by: Shirazi-Tehrani E, et al.
Published: (2020-09-01)

Carvedilol atenua o estresse oxidativo na cardiopatia chagásica crônica Carvedilol atenúa el estrés oxidativo en la cardiopatía chagásica crónica Carvedilol attenuates oxidative stress in chronic chagasic cardiomyopathy
by: Patrícia Budni, et al.
Published: (2012-03-01)

COMPARISON OF CARVEDILOL AND BISOPROLOL EFFICACY IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES TYPES 2 AFTER MYOCARDIAL INFARCTION
by: M. E. Statsenko, et al.
Published: (2016-01-01)

CARDIORENAL RELATIONS AND QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH CARVEDILOL AND BISOPROLOL
by: M. A. Statsenko, et al.
Published: (2015-12-01)

CARDIORENAL RELATIONS AND QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH CARVEDILOL AND BISOPROLOL
by: M. A. Statsenko, et al.
Published: (2015-12-01)

BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
by: I. T. Murkamilov, et al.
Published: (2017-07-01)

BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL
by: A. N. Zakirova, et al.
Published: (2016-01-01)

Hot Melt Coating of Amorphous Carvedilol
by: Jacob Bannow, et al.
Published: (2020-06-01)